Patent · US Active

Evaluating genetic disorders

US10529441B2 · kind B2 · utility

3Cited by
62References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2013
Grant dateJan 7, 2020
Priority date
Expiry dateApr 16, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B20/20
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The present invention relates to genetic analysis and evaluation utilizing copy-number variants or polymorphisms. The methods utilize array comparative genomic hybridization and PCR assays to identify the significance of copy number variations in a subject or subject group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.